Fibromyalgia
Light therapy led to improved pain, function in fibromyalgia
CHARLOTTE, N.C. — The use of morning light treatment in patients with fibromyalgia helped stabilize their sleep and led to improvements in pain and physical function, Helen J. Burgess, PhD, said at the SLEEP 2022 meeting.
Research suggests treatment of fibromyalgia should be tailored to individual symptoms
High efficacy and acceptability were demonstrated in both on-label and off-label medications for fibromyalgia, reinforcing the value of symptom-based treatment plans, according to a study published in JAMA Network Open.
Myositis Awareness Month sheds light on patient voices, disease costs
Myositis Awareness Month is focused on raising awareness and amplifying voices for patients with diseases falling under the myositis umbrella.
FDA grants marketing approval for neuromodulation device to reduce fibromyalgia symptoms
The FDA has granted De Novo authorization for NeuroMetrix to market its Quell neuromodulation device as an aid for reducing fibromyalgia symptoms in adults with high pain sensitivity, according to a company press release.
More than 40% of patients with long COVID report ‘fibromyalgia-like’ multi-site pain
More than 40% of patients with long COVID experience “fibromyalgia-like,” multisite pain, according to data released by Tonix Pharmaceuticals.
Cyclobenzaprine tablets fail phase 3 trial for fibromyalgia pain
A sublingual tablet form of the muscle relaxant cyclobenzaprine hydrochloride failed to achieve statistical significance in reducing fibromyalgia pain vs. placebo in a phase 3 trial, according to a press release.
Not 'enough studies and enough time': Data lacking for biology, timeframe on long COVID
Patients with long COVID can experience a constellation of debilitating neurological symptoms for months after infection, but the ‘underlying biology’ and a timeframe for these symptoms continue to elude clinicians, a presenter noted here.
Top in rheumatology: Fibromyalgia in US military, tapering TNF inhibitors
In the top story in rheumatology last week, new data showed that U.S. active-duty service members with PTSD had much higher rates of fibromyalgia compared with the overall population of service members who were awaiting deployment.
Fibromyalgia present in nearly 40% of US service members seeking PTSD treatment
The prevalence of fibromyalgia in U.S. active-duty service members entering treatment for PTSD is more than 10-fold higher than the overall population of service members preparing for deployment, according to data.
Nearly one-quarter of US adults have arthritis; 43% of those report activity limitations
An estimated 58.5 million adults in the United States — nearly one-quarter of the country’s adult population — had arthritis, while 25.7 million demonstrated arthritis-related activity limitations, during 2016 to 2018, according to data.